| 19-Jun-13 12:22AM | American Medical Association Decision Can Boost Arena, Vivus, And Orexigen at Seeking Alpha |
| 18-Jun-13 06:09PM | A.M.A. Recognizes Obesity as a Disease at New York Times |
| 06:09PM | A.M.A. Recognizes Obesity as a Disease at New York Times |
| 17-Jun-13 01:42PM | Consumer Reports Says "Exercise" Rather Than Take This Drug at Motley Fool |
| 11:52AM | What Investors Need To Know About The Efficacy Of Belviq at Seeking Alpha |
| 16-Jun-13 02:05PM | The Top 5 Diseases Caused by Obesity at Motley Fool |
| 14-Jun-13 09:38AM | ARENA PHARMACEUTICALS INC Files SEC form 8-K, Change in Directors or Principal Officers, Submission of Matters to a V EDGAR Online -6.71% |
| 08:00AM | BELVIQ® (lorcaserin HCl) CIV Data to be Presented at ENDO 2013 PR Newswire |
| 07:30AM | Arena Pharmaceuticals to Present at the 2013 Wells Fargo Securities Healthcare Conference PR Newswire |
| 04:13AM | Arena Pharmaceuticals: A Trading Vehicle, At Best at Seeking Alpha |
| 12:18AM | Arena's Belviq Does Not Fare Well With Consumer Reports at Seeking Alpha |
| 13-Jun-13 06:00PM | More Reasons Arena Shorts May Have It Dead Wrong at Seeking Alpha |
| 12-Jun-13 11:27AM | Why The Newest Short Thesis On Arena Is Dead Wrong And Should Be Ignored at Seeking Alpha |
| 08:57AM | Pricing MannKind Corporation On A Stand-Alone Basis at Seeking Alpha |
| 11-Jun-13 08:08PM | The Obesity-Drug Wars Officially Begin at Motley Fool |
| 06:31PM | 4 Healthcare Stock Stories For Thursday Inspection at Wall St. Cheat Sheet |
| 05:40PM | [video] Arena Pharmaceuticals CEO on Belviq at CNBC |
| 04:03PM | Arena Gets Price Target Raised To $12.50 at Seeking Alpha |
| 03:31PM | Analysts: Citigroups EPS Can Jump and 3 More Research Notes to Explore at Wall St. Cheat Sheet |
| 02:31PM | An Obesity Drug Stock to Fatten your Portfolio? at Motley Fool |
| 10-Jun-13 04:24AM | Arena's Belviq Discounts And Impacts On Revenue at Seeking Alpha |
| 09-Jun-13 02:05PM | The 3 Biggest Risk Factors for a Stroke at Motley Fool |
| 08-Jun-13 12:10PM | This Week in Biotech at Motley Fool |
| 07-Jun-13 06:49PM | 4 Healthcare Stock Stories As a Weekend Investment Prescription at Wall St. Cheat Sheet |
| 06:32PM | New Obesity Drug Hits the Market at Motley Fool |
| 02:52PM | 5 stocks insiders are buying at MarketWatch |
| 01:26PM | Arena Launches Belviq - Buying Opportunity at Seeking Alpha |
| 11:40AM | Weight loss drug Belviq gets overdue US launch AP |
| 11:22AM | TiVo Settles With Google and 3 More Hot Stocks at Wall St. Cheat Sheet |
| 11:12AM | Weight loss drug Belviq gets overdue US launch AP |
| 10:39AM | Weight loss drug Belviq gets overdue US launch AP |
| 09:07AM | ARENA PHARMACEUTICALS INC Files SEC form 8-K, Other Events EDGAR Online |
| 08:06AM | InPlay: Arena Pharm reported today on the launch of BELVIQ; BELVIQ will be available to patients by prescription in US pharmacies beginning June 11 Briefing.com |
| 08:05AM | Arena Pharmaceuticals Reports on Launch of BELVIQ® (lorcaserin HCl) CIV for Chronic Weight Management in Adults who are Overweight with a Comorbidity or Obese PR Newswire |
| 06-Jun-13 12:20AM | Vivus Fighting 3 Front War at Seeking Alpha |
| 05-Jun-13 07:57AM | Monday's Top Biotech Losers Infinity And Synta And Other Top Sells By Fund Managers at Seeking Alpha |
| 03:23AM | Arena's Belviq Set To Launch at Seeking Alpha |
| 04-Jun-13 12:43PM | Will Arena Pharmaceuticals See Rising Prices? at Wall St. Cheat Sheet |
| 11:56AM | Arena And Vivus Investors: Do Not Fear A Market Correction at Seeking Alpha |
| 07:55AM | Trius Therapeutics: The Next Big Small-Cap Biotech Mover? at Seeking Alpha |
| 06:55AM | The Key To Creating Large Gains: Patience at Seeking Alpha |
| 04:05AM | A Study Of Arena's Lorcaserin Against The Backdrop Of Several Anti-Obesity Mechanisms at Seeking Alpha |
| 03-Jun-13 07:19AM | Did Arena Mislead Investors About Its Share Of Belviq's Profits? at Seeking Alpha |
| 12:14AM | Aegerion And Other Top Small-Cap Biotech Buys By Mega Funds In March 2013 Quarter at Seeking Alpha |
| 31-May-13 01:46PM | Stocks to Buy: Biotechs With Growth Potential at Motley Fool |
| 08:03AM | 5 Worst Biotechs of 2013 at Motley Fool |
| 01:31AM | The Arena Pipeline Potential at Seeking Alpha |
| 30-May-13 05:24PM | Arena Pharmaceuticals' Management Presents at Deutsche Bank dbAccess Health Care Conference (Transcript) at Seeking Alpha |
| 08:18AM | Is Novo A Threat To Arena, Vivus, And Orexigen? at Seeking Alpha |
| 29-May-13 07:11PM | Arena: Marketing An Anti-Obesity Drug at Seeking Alpha |
| 04:14PM | Arena Stock Falls On Unusually High Volume (ARNA) at TheStreet |
| 02:50PM | This Obesity Drugmaker Is Badly In Need of a Marketing Partner at Motley Fool |
| 02:37PM | Commit To Buy Arena Pharmaceuticals At $5, Earn 20.2% at Forbes |
| 01:45PM | 3 Big Reasons to Own Johnson & Johnson Stock at Motley Fool |
| 09:39AM | The Newest Obesity Drug Player at Motley Fool |
| 09:27AM | Sales Estimates For Arena's Belviq Are Too Low And Shares Are Undervalued at Seeking Alpha |
| 08:11AM | Today's Market News To Trade On: 5 Stocks Moving On News at Seeking Alpha |
| 01:56AM | Arena Surges On Pre-Launch at Seeking Alpha |
| 28-May-13 11:34AM | Arena Pharmaceuticals (ARNA) Shares Cross Above 200 DMA at TheStreet +7.71% |
| 01:21AM | Sirius XM And Arena Pharmaceuticals - More Parallels Than You Think at Seeking Alpha |
| 27-May-13 08:00AM | 2 Biotech Stocks in Activist Investors' Crosshairs at Motley Fool |
| 26-May-13 02:15PM | The 7 Most Obese U.S. States at Motley Fool |
| 25-May-13 03:10PM | The 7 Least Obese U.S. States at Motley Fool |
| 02:15PM | The Top 3 Causes of Diabetes at Motley Fool |
| 24-May-13 10:27AM | Why This Obesity Drug Is the Sector's Best Bet at Motley Fool |
| 08:00AM | Arena Pharmaceuticals to Present at Two Upcoming Investor Conferences PR Newswire |
| 06:20AM | Novo obesity drug could launch in U.S. end 2014 at Reuters |
| 02:53AM | Arena - Good Sales, Bad Sales, Long And Short at Seeking Alpha |
| 12:06AM | First Manhattan Still Playing Hardball With Vivus at Seeking Alpha |
| 23-May-13 03:08PM | Arena Is Still A Great Short at Seeking Alpha |
| 01:55PM | Why This Obesity Drug Is the Sector's Best Bet at Motley Fool |
| 01:20PM | Arena Buyout More 'Highly Probable' Than MannKind at Seeking Alpha |
| 22-May-13 11:06PM | Why Doctors Can Prescribe Arena's Belviq For Off Label Uses Without Worrying About Legal Liability at Seeking Alpha |
| 08:56PM | 3 Pipeline Obesity Treatments You Should Watch at Motley Fool |
| 03:19AM | Arena Pharmaceuticals - Out To Launch Or Out To Lunch? at Seeking Alpha |
| 21-May-13 06:56AM | The Facebook Effect On Arena's Belviq Sales And Why It Will Ultimately Dwarf Anything Eisai Does at Seeking Alpha |
| 20-May-13 02:06PM | The 9 Most Obese Countries in the World at Motley Fool |
| 03:05AM | Arena NOLs Will Come Into Play Soon at Seeking Alpha |
| 19-May-13 09:41AM | Vivus Taps Into More Cash at Seeking Alpha |
| 18-May-13 08:01AM | 25 Belt-Busting Obesity Facts at Motley Fool |
| 17-May-13 01:04PM | ARENA PHARMACEUTICALS INC Financials EDGAR Online Financials |
| 02:01AM | Arena Outlines Belviq Launch And Goals at Seeking Alpha |
| 15-May-13 07:04PM | Weight Loss Isn't Just for Looking Good Anymore at Motley Fool |
| 10:18AM | Vivus - Mild Drama Continues at Seeking Alpha |
| 08:42AM | Will Obesity Drugs Gain Soon? at Motley Fool |
| 14-May-13 05:49AM | Looking at Arena Following Sell-Off at Motley Fool |
| 05:42AM | Vivus Starting To Gain The Advantage Over Arena at Seeking Alpha |
| 01:16AM | Shorting Arena Is Not a Good Idea Now at Motley Fool |
| 01:08AM | Arena, Vivus, And Off-Label Prescriptions at Seeking Alpha |
| 11-May-13 03:00PM | Deal Discussions Distract From Disappointing Obesity Drug Sales at Motley Fool |
| 09:53AM | Why Does Arena's Obesity Drug Have Abuse Potential? at Forbes |
| 10-May-13 02:31PM | Belviq's Sales Will Disappoint: Demographics Matter at Seeking Alpha |
| 08:00AM | Arena Pharmaceuticals to Present at the Bank of America Merrill Lynch 2013 Health Care Conference PR Newswire |
| 02:07AM | Vivus Shifting Gears at Seeking Alpha |
| 12:21AM | For Arena, Sales Is Key at Seeking Alpha |
| 09-May-13 08:16PM | Is the Golden Age of Blockbusters Over? at Motley Fool |
| 03:20PM | ARNA Sheds Light on Belviq Launch Zacks |
| 10:11AM | ARENA PHARMACEUTICALS INC Files SEC form 10-Q, Quarterly Report EDGAR Online |
| 08:35AM | VIVUS Reports Wider Loss Zacks |
| 07:12AM | Obesity Drug Demand Still Low at Motley Fool |
